U.S. Markets closed

Nuvo Pharmaceuticals Inc. (NRI.TO)


Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
3.95-0.05 (-1.25%)
At close: 3:57PM EDT
Full screen
Previous Close4.00
Open3.92
Bid3.91 x
Ask3.94 x
Day's Range3.90 - 4.00
52 Week Range3.90 - 8.35
Volume26,101
Avg. Volume23,634
Market Cap45.63M
Beta-0.01
PE Ratio (TTM)5.92
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Associated Press2 months ago

    Nuvo Research posts 1Q profit

    The Mississauga, Ontario-based company said it had profit of 14 cents per share. The drugmaker posted revenue of $5.3 million in the period. In the final minutes of trading on Wednesday, the company's ...

  • Associated Press5 months ago

    Nuvo Research posts 4Q profit

    On a per-share basis, the Mississauga, Ontario-based company said it had net income of 11 cents. The drugmaker posted revenue of $4.2 million in the period. For the year, the company reported net income ...

  • Nuvo Pharmaceuticals, Inc. :NRI-CA: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016
    Capital Cube8 months ago

    Nuvo Pharmaceuticals, Inc. :NRI-CA: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016

    Categories: Yahoo Finance Get free summary analysis Nuvo Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Nuvo Pharmaceuticals, Inc. – Valeant Pharmaceuticals International Inc, Theratechnologies Inc., Cipher Pharmaceuticals Inc. and BELLUS Health Inc. (VRX-CA, TH-CA, CPH-CA and BLU-CA) that have also reported for this ... Read more (Read more...)